----

| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---------|--------------------------------------------------------------------------------------|
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---------|------------------------------------------------------------------------------------------|
| Israel                                                        | Not applicable                      |
|---------------------------------------------------------------|-------------------------------------|
| (State or other jurisdictionof incorporation or organization) | (I.R.S. EmployerIdentification No.) |
| 3 Hatnufa Street, Floor 6Yokneam Ilit, Israel | 2069203    |
|-----------------------------------------------|------------|
| (Address of principal executive offices)      | (Zip Code) |
| Title of Each Class:                          | Trading Symbol(s) | Name of Each Exchange on Which Registered |
|-----------------------------------------------|-------------------|-------------------------------------------|
| Ordinary Shares, par value NIS 0.25 per share | RWLK              | The Nasdaq Stock Market LLC               |

----

| Large accelerated filer | ☐ | Accelerated filer         | ☐ |
|-------------------------|---------|---------------------------|---------|
| Non-accelerated filer   | ☒ | Smaller reporting company | ☒ |
|                    |    | Emerging growth company   | ☐ |

----

----

| Item     |                                                                                           | Page   |
|----------|------------------------------------------------------------------------------------------------|--------|
|     |
| PART III |
|     |                                                                                                |   |
| 10.      | Directors, Executive Officers and Corporate Governance                                         | 1      |
|     |                                                                                           |   |
| 11.      | Executive Compensation                                                                         | 7      |
|     |                                                                                           |   |
| 12.      | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 20     |
|     |                                                                                           |   |
| 13.      | Certain Relationships and Related Transactions, and Director Independence                      | 23     |
|     |                                                                                           |   |
| 14.      | Principal Accounting Fees and Services                                                         | 29     |
|     |                                                                                           |   |
| PART IV  |
|     |                                                                                           |   |
| 15.      | Exhibits, Financial Statement Schedules                                                        | 30     |

----

| Name                             | Age | Current Position with the Company          | Director Since |
|----------------------------------|-----|--------------------------------------------|----------------|
| Jeff Dykan*(1)                   | 61  | Class I Director, Chairman                 | 2009           |
| Yasushi Ichiki*                  | 52  | Class I Director                           | 2014           |
| Larry Jasinski                   | 63  | Class II Director, Chief Executive Officer | 2012           |
| Dr. John William Poduska*(2) (3) | 82  | Class II Director                          | 2014           |
| Randel E. Richner*               | 65  | Class II Director                          | November 2020  |
| Wayne B. Weisman*(3)             | 64  | Class III Director                         | 2009           |
| Aryeh (Arik) Dan*(1)(2)          | 61  | Class III Director                         | 2013           |
| Yohanan Engelhardt*(3)           | 62  | Class III Director                         | 2018           |

----

----

----

| Name           |   | Age |   | Position                                                                                            |
|----------------|--------|-----|--------|-----------------------------------------------------------------------------------------------------|
| Larry Jasinski |   | 63  |   | Chief Executive Officer and Director                                                                |
| Ori Gon        |   | 39  |   | Chief Financial Officer                                                                             |
| Ofir Koren(1)  |   | 51  |   | General Manager -ReWalk Robotics Ltd. and Vice President, Research & Development and Regulatory |
|  |  | (1) Mr. Koren intends to resign as Vice President, Research & Development and Regulatory, effective January 17, 2021. Mr. Koren will continue to support the Company until February 28, 2021 in certain regulatory matters. |
|--|--|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

| Name and              Principal              Position            |   |   | Year |   | Salary              ($) |    |   | Non-Equity Incentive Plan              ($)(1) |   |   | Stock Awards($)(2) |   |   | Option Awards($)(2) |   |   | All Other Compensation              ($)(3) |    |   | Total              ($) |   |
|------------------------------------------------------------------|--------|--------|------|--------|-------------------------|---------|--------|-----------------------------------------------|--------|--------|--------------------|--------|--------|---------------------|--------|--------|--------------------------------------------|---------|--------|------------------------|--------|
| Larry Jasinski,Chief Executive                                   |   |   | 2019 |   |                    | 391,400 |   |                                          |   | 82,194 |               |   |   | 13,320              | (5)    |   |                                       | 66,598  | (7)    |                   |   | - |   |   |   | 553,512 |   |
| Officer and Director(4)                                          |   |   | 2018 |   |                    | 388,550 |   |                                          |   | 98,936 |               |   |   | 47,031              | (6)    |   |                                       | 235,156 | (8)    |                   |   | - |   |   |   | 769,673 |   |
| OriGon,                                                          |   |   | 2019 |   |                    | 177,695 |   |                                          |   | 15,778 |               |   |   | 14,175              | (10)   |   | -                                          |    |   |                   | 69,195 | (13) |   |   | 276,843 |   |
| Chief Financial Officer(9)                                       |   |   | 2018 |   |                    | 163,327 |   |                                          |   | 17,348 |               |   |   | 34,645              | (11)   |   |                                       | 181,551 | (12)   |                   |   | 65,078 | (14) |   |   | 461,949 |   |
| Ofir Koren,                                                      |   |   | 2019 |   |                    | 194,075 |   |                                          |   | 17,233 |               |   |   | 11,812              | (15)   |   | -                                          |    |   |                   | 75,665 | (18) |   |   | 298,785 |   |
| Vice President, Research & Development and Regulatory(9)(20) |   |   | 2018 |   |                    | 185,162 |   |                                          |   | 18,947 |               |   |   | 14,109              | (16)   |   |                                       | 70,547  | (17)   |                   |   | 76,971 | (19) |   |   | 365,736 |   |
| (1) | Represents one-time discretionary cash bonuses to each of the Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Amounts represent the aggregate grant date fair value of such awards computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“FASB ASC              Topic 718”). The fair value of Restricted Stock Units (RSUs) granted is determined based on the price of the Company’s ordinary shares on the date of grant. The fair value of options awards was estimated at the date of grant using a              Black-Scholes-Merton option pricing model with assumptions related to expected volatility, risk free rate, dividend yield, expected term (in years) and ReWalk share price. |
| (3) | Amounts reported in this column include benefits and perquisites, including those mandated by Israeli law. Such benefits and perquisites include payments, contributions and/or allocations for              social benefits and car expenses.                                                                                                                                                                                                                                                                                                                                                                                                                |
| (4) | Mr. Jasinski does not receive any additional compensation for his services as a director. See “Director Compensation” above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| (5) | Consists of 2,485 RSUs that were granted under the 2014 Plan to Mr. Jasinski on March 27, 2019, which vest ratably in four equal annual installments starting on the first anniversary of the              grant date.                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| (6) | Consists of 43,750 RSUs that were granted under the 2014 Plan to Mr. Jasinski on May 3, 2018, which vest ratably in four equal annual installments starting on the first anniversary of the              grant date.                                                                                                                                                                                                                                                                                                                                                                                                                                          |

----

| (7)  | Consists of options to purchase 12,425 ordinary shares that were granted to Mr. Jasinski on March 27, 2019, with 25% of the options to vest on the first anniversary of the grant date and              6.25% of the options to vest and become exercisable on a quarterly basis thereafter. The options will also vest as follows: (A) 100% of the then-unvested options shall automatically vest upon the occurrence of an “Exit Event” (as defined              below in this footnote) and the termination of Mr. Jasinski’s employment within 12 months following such Exit Event, other than a termination for cause (as defined in Mr. Jasinski’s employment agreement with the Company, as described below);              or (B) upon a termination of Mr. Jasinski’s employment by the ReWalk Robotics, Inc., our wholly-owned U.S. subsidiary (the “Subsidiary”) without “cause” or by Mr. Jasinski for “Good Reason” (both as defined in Mr. Jasinski’s employment              agreement) prior to an Exit Event, any unvested options that would have vested during the six months following the effective date of such termination had Mr. Jasinski remained employed by the Subsidiary during such period will automatically              vest. “Exit Event” means (i) a sale of all or substantially all of the assets of the Company, (ii) a sale (including an exchange) of all or substantially all of the shares of the Company, (iii) a merger, acquisition, consolidation or              amalgamation in which the Company is not the surviving corporation, (iv) a reverse merger in which the Company is the surviving corporation but the shares of the Company outstanding immediately preceding the merger are converted by virtue of              the merger into other property, whether in the form of securities and/or cash or otherwise, (v) a scheme of arrangement for the purpose of effecting such sale, merger, acquisition, consolidation or amalgamation or (vi) such other transaction              that is determined by the Board to be a transaction having a similar effect. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (8)  | Consists of options to purchase 218,750 ordinary shares that were granted under the 2014 Plan to Mr. Jasinski on May 3, 2018, with 25% of the options to vest on the first anniversary of the              grant date and 6.25% of the options to vest and become exercisable on a quarterly basis thereafter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| (9)  | The amounts set forth for each of Mr. Gon and Mr. Koren in the columns “Salary,” “Non-Equity Incentive Plan,” and “All Other Compensation” represent payments, contributions and/or allocations              that were made in NIS, and have been translated to US dollars according to the average exchange rate on the applicable period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| (10) | Consists of 4,500 RSUs that were granted under the 2014 Plan to Mr. Gon on June 1, 2019, which vest ratably in three equal annual installments starting on the first anniversary of the grant.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| (11) | Consists of 17,857 RSUs that were granted under the 2014 Plan to Mr. Gon on February 22, 2018 in connection with his appointment as Chief Financial Officer, and 13,125 RSUs that were granted              to Mr. Gon on May 3, 2018. The RSUs vest ratably in four equal annual instalments starting on the first anniversary of the applicable grant date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (12) | Consists of options to purchase 96,525 ordinary shares that were granted under the 2014 Plan to Mr. Gon on February 22, 2018 in connection with his appointment as Chief Financial Officer, and              options to purchase 65,625 ordinary shares that were granted under the 2014 Plan to Mr. Gon on May 3, 2018, with 25% of the options to vest on the first anniversary of the applicable grant date and 6.25% of the options to vest and become              exercisable on a quarterly basis thereafter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| (13) | Consists of $50,679 for payments, contributions and/or allocations for social benefits and the aggregate incremental cost to the Company of $18,516 with respect to Mr. Gon’s personal use of a              Company-leased car.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| (14) | Consists of $47,424 for payments, contributions and/or allocations for social benefits and the aggregate incremental cost to the Company of $17,654 with respect to Mr. Gon’s personal use of a              Company-leased car.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| (15) | Consists of 3,750 RSUs that were granted under the 2014 Plan to Mr. Koren on June 1, 2019, which vest ratably in three equal annual installments starting on the first anniversary of the grant              date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| (16) | Consists of 13,125 RSUs that were granted to Mr. Koren on May 3, 2018, which vest ratably in four equal annual installments starting on the first anniversary of the grant date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| (17) | Consists of options to purchase 65,625 ordinary shares that were granted under the 2014 Plan to Mr. Koren on May 3, 2018, with 25% of the options to vest on the first anniversary of the grant              date and 6.25% of the options to vest and become exercisable on a quarterly basis thereafter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| (18) | Consists of $53,201 for payments, contributions and/or allocations for social benefits and the aggregate incremental cost to the Company of $22,464 with respect to Mr. Koren’s personal use of              a Company-leased car.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| (19) | Consists of $51,231 for payments, contributions and/or allocations for social benefits and the aggregate incremental cost to the Company of $25,740 with respect to Mr. Koren’s personal use of              a Company-leased car.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| (20) | Mr. Koren intends to resign as Vice President, Research & Development and Regulatory, effective January 17, 2021. Mr. Koren will continue to support the Company until February 28, 2021 in              certain regulatory matters.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

----

----

----

----

|           |   |          |        | Option Awards                                                                                                                                     |   | Stock Awards                                                                                                                                        |
|----------------|--------|---------------|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------|
| Name           |   | Grant Date(1) |        | Number of              Securities              Underlying              Unexercised              Options              Exercisable              (#) |   | Number of              Securities              Underlying              Unexercised              Options              Unexercisable              (#) |   | Option              Exercise              Price ($) |   | Option              Expiration              Date |   | Number of              Shares or              Units of              Stock              that Have              Not Vested (#) |   | Market              Value of              Shares or              Units of              Stock that              Have Not Vested(2)($) |
| Larry Jasinski |   | 5/1/2012      | ​(3)  |                                                                                                                                              | 6,619  |                                                                                                                                                | - |   | 32.93 |   | 5/1/2022 |   |   |   |   |
|           |   | 5/10/2012     | ​(4)  |                                                                                                                                              | 3,308  |                                                                                                                                                | - |   | 32.93 |   | 5/10/2022 |   |   |   |   |
|           |   | 12/24/2013    | ​(5)  |                                                                                                                                              | 5,641  |                                                                                                                                                | - |   | 37.14 |   | 12/24/2023 |   |   |   |   |
|           |   | 6/27/2017     | ​(6)  |                                                                                                                                              | 1,875  |                                                                                                                                                | 3,125 |   | 52.50 |   | 6/27/2027 |   |   |   |   |
|           |   | 5/3/2018      | ​(7)  |                                                                                                                                              | 3,281  |                                                                                                                                                | 5,468 |   | 26.88 |   | 5/3/2028 |   |   |   |   |
|           |   | 3/27/2019     | (8)         |                                                                                                                                              | -      |                                                                                                                                                | 12,425 |   | 5.37 |   | 3/27/2029 |   |   |   |   |
|           |   | 5/24/2016     | ​(9)  |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 100 |   | 216 |
|           |   | 6/27/2017     | ​(10) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 500 |   | 1,080 |
|           |   | 10/5/2017     | ​(11) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 1,045 |   | 2,257 |
|           |   | 5/3/2018      | ​(12) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 1,313 |   | 2,836 |
|           |   | 3/27/2019     | ​(13) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 2,485 |   | 5,368 |
| Ori Gon        |   | 2/22/2018     | ​(14) |                                                                                                                                              | 1,689  |                                                                                                                                                | 2,172 |   | 28.75 |   | 2/22/2028 |   |   |   |   |
|           |   | 5/3/2018      | ​(7)  |                                                                                                                                              | 984    |                                                                                                                                                | 1,641 |   | 27.11 |   | 5/3/2028 |   |   |   |   |
|           |   | 5/18/2016     | ​(15) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 38 |   | 82 |
|           |   | 4/18/2017     | ​(16) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 150 |   | 324 |
|           |   | 10/5/2017     | ​(11) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 31 |   | 67 |
|           |   | 2/22/2018     | ​(17) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 535 |   | 1,156 |
|           |   | 5/03/2018     | ​(12) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 394 |   | 851 |
|           |   | 6/01/2019     | ​(18) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 4,500 |   | 9,720 |
| Ofir Koren     |   | 7/17/2013     | ​(19) |                                                                                                                                              | 75     |                                                                                                                                                | - |   | 32.93 |   | 7/17/2023 |   |   |   |   |
|           |   | 12/24/2013    | ​(20) |                                                                                                                                              | 676    |                                                                                                                                                | - |   | 37.14 |   | 12/24/2023 |   |   |   |   |
|           |   | 4/18/2017     | ​(21) |                                                                                                                                              | 937    |                                                                                                                                                | 563 |   | 50.00 |   | 4/18/2027 |   |   |   |   |
|           |   | 5/3/2018      | ​(7)  |                                                                                                                                              | 984    |                                                                                                                                                | 1,641 |   | 26.88 |   | 5/3/2028 |   |   |   |   |
|           |   | 5/18/2016     | ​(15) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 34 |   | 73 |
|           |   | 4/18/2017     | ​(16) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 150 |   | 324 |
|           |   | 10/5/2017     | ​(11) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 180 |   | 389 |
|           |   | 5/3/2018      | ​(12) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 394 |   | 851 |
|           |   | 6/1/2019      | ​(18) |                                                                                                                                              |   |                                                                                                                                                |   |   |   |   |   |   | 3,750 |   | 8,100 |
| (1)  | Represents grant dates of the stock option and RSU awards.                                                                                                                                                                                                                                            |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)  | The amount listed in this column represents the product of the closing market price of the Company’s ordinary shares as of December 31, 2019 ($2.16) multiplied by the number of shares subject              to the award.                                                                      |
| (3)  | Option awards became vested and exercisable a rate of 1/12th the original number of ordinary shares subject thereto on a quarterly basis commencing on May 1, 2012.                                                                                                                                   |
| (4)  | Option awards became vested and exercisable a rate of 1/12th the original number of ordinary shares subject thereto on a quarterly basis commencing on May 10, 2012.                                                                                                                                  |
| (5)  | Option awards became vested and exercisable a rate of 1/48th the original number of ordinary shares subject thereto on a quarterly basis commencing on January 23, 2014.                                                                                                                              |
| (6)  | Option awards vested with respect to 1/4th of the original number of ordinary shares subject thereto on June 27, 2018 and vest thereafter at a rate of 1/16th of the original number of shares              on a quarterly basis commencing on September 27, 2018 and ending on June 27, 2021.        |
| (7)  | Option awards vest with respect to 1/4th of the original number of ordinary shares subject thereto on May 3, 2019 and thereafter at a rate of 1/16th of the original number of shares on a              quarterly basis commencing on August 3, 2019 and ending on May 3, 2022.                       |
| (8)  | Option awards vest with respect to 1/4th of the original number of ordinary shares subject thereto on March 27, 2020 and thereafter at a rate of 1/16th of the original number of shares on a              quarterly basis commencing on June 27, 2019 and ending on March 27, 2023.                  |
| (9)  | RSUs vested with respect to 1/4th of the original number of ordinary shares subject thereto on May 24, 2017 and vest thereafter at a rate of 1/16th of the original number of shares on a              quarterly basis commencing on August 24, 2017 and ending on May 24, 2020.                      |
| (10) | RSUs vested with respect to 1/4th of the original number of shares on an annual basis commencing on June 27, 2018 and ending on June 27, 2021.                                                                                                                                                        |
| (11) | RSUs vested with respect to 1/3rd of the original number of shares on an annual basis commencing on October 5, 2018 and ending on October 5, 2020. The RSUs were granted in connection with the              cancellation of certain underwater stock options as part of the Equity Exchange Program. |
| (12) | RSUs vested with respect to 1/4th of the original number of shares on an annual basis commencing on May 3, 2019 and ending on May 3, 2022.                                                                                                                                                            |
| (13) | RSUs vested with respect to 1/3rd of the original number of shares on an annual basis commencing on March 27, 2020 and ending on March 27, 2022                                                                                                                                                       |
| (14) | Option awards vest with respect to 1/4th of the original number of ordinary shares subject thereto on February 22, 2019 and thereafter at a rate of 1/16th of the original number of shares on              a quarterly basis commencing on May 22, 2019 and ending on May 22, 2022.                  |
| (15) | RSUs vested with respect to 1/4th of the original number of ordinary shares subject thereto on May 18, 2017 and vested thereafter at a rate of 1/16th of the original number of shares on a              quarterly basis commencing on August 18, 2017 and ending on May 18, 2020.                    |
| (16) | RSUs vested with respect to 1/4th of the original number of shares on an annual basis commencing on April 18, 2018 and ending on April 18, 2021.                                                                                                                                                      |
| (17) | RSUs vested with respect to 1/4th of the original number of ordinary shares subject thereto on February 22, 2019 and vest thereafter at a rate of 1/16th of the original number of shares on a              quarterly basis commencing on May 22, 2019 and ending on May 22, 2022.                    |
| (18) | RSUs vest with respect to 1/3rd of the original number of shares on an annual basis commencing on June 1, 2020 and ending on June 1, 2022                                                                                                                                                             |
| (19) | Option awards vested with respect to 1/48th of the original number of ordinary shares subject thereto on July 17, 2014, and vested thereafter at a rate of 1/48th of the original number of              shares on a monthly basis ending on June 1, 2017.                                            |
| (20) | Option awards vested with respect to 1/48th of the original number of ordinary shares subject thereto on January 24, 2014, and vested thereafter at a rate of 1/48th of the original number of              shares on a monthly basis ending on December 1, 2017.                                     |
| (21) | Option awards vested with respect to 1/4th of the original number of ordinary shares subject thereto on April 18, 2018 and vest thereafter at a rate of 1/16th of the original number of shares              on a quarterly basis commencing on July 18, 2018 and ending on April 18, 2021.           |

----

----

----

----

----

----

| Name                     |   | Fees Earned              in Cash ($) |   |   | RSU Awards              ($) |   |   | Total              ($) |   |
|--------------------------|--------|--------------------------------------|--------|--------|-----------------------------|--------|--------|------------------------|--------|
| Jeff Dykan               |   |                                 | -      |   |                        |   | 25,000 | (1)                    |   |   | 25,000 |   |
| Ning Cong                |   |                                 | -      |   |                        |   | 25,000 | (1)(2)                 |   |   | 25,000 |   |
| Aryeh (Arik) Dan         |   |                                 | -      |   |                        |   | 25,000 | (1)                    |   |   | 25,000 |   |
| Yohanan Engelhardt       |   |                                 | 45,313 | (4)    |                        |   | 25,000 | (1)                    |   |   | 70,313 |   |
| Chunlin (Allen) Han      |   |                                 |   |   |                        |   | 30,000 | (2)(3)                 |   |   | 30,000 |   |
| Yasushi Ichiki           |   |                                 | -      |   |                        |   | 25,000 | (1)                    |   |   | 25,000 |   |
| Dr. John William Poduska |   |                                 | 48,949 | (5)    |                        |   | 25,000 | (1)                    |   |   | 73,949 |   |
| Peter Wehrly             |   |                                 | 38,608 | (6)    |                        |   | 25,000 | (1)                    |   |   | 63,608 |   |
| Wayne B. Weisman         |   |                                 | -      |   |                        |   | 25,000 | (1)                    |   |   | 25,000 |   |
| (1) | Amounts represent the aggregate grant date fair value of an award of 4,659 RSUs issued under the 2014 Equity Incentive Plan (the “2014 Plan”) as an annual award to the applicable directors, computed in accordance              with FASB ASC Topic 718. The fair value of RSUs granted is determined based on the price of the Company’s ordinary shares on the date of grant. All RSUs become vested and exercisable in four equal quarterly installments starting three months              following the grant date. The valuation assumptions used in determining such amounts are described in Notes 2k and 8c to our consolidated financial statements included in our Original Form 10-K. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Ms. Cong, who was designated by our shareholder Timwell Corporation Limited (“Timwell”), resigned from the Board of Directors effective May 14, 2019, and the 4,659 RSUs that were granted to her as an annual award              to incumbent directors were terminated prior to the vesting of any RSUs under such grant. Mr. Han replaced her as Timwell’s designee effective on May 15, 2019, and was removed without cause by the Board effective April 7, 2020.                                                                                                                                                                                                                               |
| (3) | Amounts represent the aggregate grant date fair value of an award of 11,029 RSUs under the 2014 Plan, computed in accordance with FASB ASC Topic 718. The fair value of RSUs granted is determined based on the              price of the Company’s ordinary shares on the date of grant. All RSUs become vested and exercisable in four equal quarterly installments starting three months following the grant date. The valuation assumptions used in determining such              amounts are described in Notes 2k and 8c to our consolidated financial statements included in our Original Form 10-K.                                                                                                     |
| (4) | Represents $23,638 earned by Mr. Engelhardt as an annual retainer for serving as an external director on the Board of Directors, $13,232 for attending meetings of the Board of Directors, $4,577 for serving as the              chairman of the audit committee and $3,866 for serving as a member of the Company’s finance committee established for its securities offerings. For more information on external directors, see “Opt-Out of Certain Israel Companies Law              Requirements” above.                                                                                                                                                                                        |

----

| (5) | Represents $23,638 earned by Dr. Poduska as an annual retainer for serving as an external director on the Board of Directors, $12,676 for attending meetings of the Board of Directors, $4,577 for serving as a              member of the audit committee, $4,192 for serving as the chairman of the compensation committee and $3,866 for serving as a member of the Company’s finance committee established for its securities offerings. For more information on external              directors, see “Opt-Out of Certain Israel Companies Law Requirements” above. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (6) | Represents $23,638 earned by Mr. Wehrly as a portion of the annual retainer for serving as a member of the Board of Directors, $10,775 for attending meetings of the Board of Directors and $4,195 for serving as a              member of the audit committee. Mr. Wehrly resigned from the Board of Directors effective March 15, 2020.                                                                                                                                                                                                                                                 |
| Name                     |   | Number of Shares |   |
|--------------------------|--------|------------------|--------|
| Jeff Dykan               |   |             | 1,666  | (1) |
| Ning Cong                |   |             | -      |   |
| Aryeh (Arik) Dan         |   |             | 1,666  |   |
| Yohanan Engelhardt       |   |             | 1,165  |   |
| Chunlin (Allen) Han      |   |             | 5,515  |   |
| Yasushi Ichiki           |   |             | 1,666  |   |
| Dr. John William Poduska |   |             | 2,167  |   |
| Peter Wehrly             |   |             | 2,000  |   |
| Wayne B. Weisman         |   |             | 1,666  | (2) |
| (1) | See “Security Ownership of Certain Beneficial Owners and Management” above for further information on Mr. Dykan’s holdings in our ordinary shares.   |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | See “Security Ownership of Certain Beneficial Owners and Management” above for further information on Mr. Weisman’s holdings in our ordinary shares. |

----

----

| Name                                                             |   | Number of Shares |      |   | Percentage of Shares |   |
|------------------------------------------------------------------|--------|------------------|-----------|--------|----------------------|--------|
| 5%-or-More Beneficial Owners:                                    |   |             |      |   |                 |   |
| Intracoastal Capital, LLC(1)                                     |   |             | 2,450,965 |   |                 |   | 9.99 | % |
| Armistice Capital Master Fund, Ltd.(2)                           |   |             | 1,394,944 |   |                 |   | 5.63 | % |
| Named Executive Officers and Directors:                          |   |             |      |   |                 |   |   |   |
| Larry Jasinski(3)                                                |   |             | 36,842    |   |                 |   | * |   |
| Jeff Dykan(4) (5)                                           |   |             | 66,479    |   |                 |   | * |   |
| Yohanan Engelhardt(6)                                            |   |             | 11,223    |   |                 |   | * |   |
| Wayne B. Weisman(4) (7)                                          |   |             | 71,787    |   |                 |   | * |   |
| Aryeh (Arik) Dan(7)                                              |   |             | 11,784    |   |                 |   | * |   |
| Yasushi Ichiki(7)                                                |   |             | 11,784    |   |                 |   | * |   |
| Randel Richner(8)                                                |   |             | 6,874     |   |                 |   | * |   |
| Dr. John William Poduska(9)                                      |   |             | 12,285    |   |                 |   | * |   |
| Ofir Koren(10)                                                   |   |             | 6,118     |   |                 |   | * |   |
| Ori Gon(11)                                                      |   |             | 17,044    |   |                 |   | * |   |
| All directors and executive officers as a group (10 persons)(12) |   |             | 192,217   |   |                 |   | * |   |
|  * | Ownership of less than 1%.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)     | Holds (i) 871,840 ordinary shares, all of which are December 2020 Shares and ordinary shares underlying currently exercisable warrants to purchase              up to an aggregate of 1,972,122 ordinary shares, including 653,880 ordinary shares underlying the December 2020 Warrants, with the remaining ordinary shares underlying the February 2020 Institutional Warrants, the November 2016 Oppenheimer              Warrants, April 2019 Institutional Warrants, June 2019 Institutional Warrants and July 2020 Institutional Warrants. However, as a result of beneficial ownership limitations in the outstanding warrants, Intracoastal is only deemed to              beneficially own for purposes of this table 2,450,965 ordinary shares, or 9.99% of our total outstanding ordinary shares. Mitchell P. Kopin and Daniel B. Asher, each of whom are managers of Intracoastal LLC (“Intracoastal”), have shared              voting control and investment discretion over the securities held by Intracoastal. As a result, each of Mr. Kopin and Mr. Asher may be deemed to have beneficial ownership over such shares of Intracoastal. The principal business address of              Intracoastal is 245 Palm Trail, Delray Beach, FL 33482.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| (2)     | Holds (i) 1,394,944 ordinary shares, all of which are December 2020 Shares and (ii) ordinary shares underlying currently exercisable warrants to              purchase up to an aggregate of 4,253,021 ordinary shares, including 1,046,208 ordinary shares underlying the December 2020 Warrants, with the remaining ordinary shares underlying the June 2019 Institutional Warrants, February 2020 Common              Warrants and July 2020 Institutional Warrants. However, as a result of 4.99% beneficial ownership limitations in the outstanding warrants, Armistice Capital Master Fund, Ltd. (“Armistice”) is only deemed to beneficially own 1,394,944 ordinary              shares for purposes of this table. Armistice Capital, LLC, the investment manager of Armistice, and Steven Boyd, the managing member of Armistice Capital, LLC, hold shared voting and dispositive power over the shares held by Armistice. The              principal business address of Armistice is c/o Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, NY 10022.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| (3)     | Consists of 5,451 ordinary shares,   and exercisable options to purchase 31,391  ordinary shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| (4)     | Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P., or SCP Vitalife              Partners II, a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P., or SCP Vitalife Partners Israel II, a limited partnership organized in Israel, 2,480              ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P., or Vitalife Partners Overseas, 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P., or Vitalife Partners Israel, 829 ordinary shares beneficially              owned by Vitalife Partners (D.C.M) L.P., or Vitalife Partners DCM, and 1,571 ordinary shares currently held by the Israel Innovation Authority (formerly known as the Office of the Chief Scientist of the State of Israel), or the IIA, that              Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. SCP Vitalife II Associates, L.P., or SCP Vitalife Associates, a limited partnership organized in the Cayman Islands, is the              general partner of the SCP Vitalife Partners II and SCP Vitalife Partners Israel II, and SCP Vitalife II GP, Ltd., or SCP Vitalife GP, organized in the Cayman Islands, is the general partner of SCP Vitalife Associates. As such, SCP Vitalife              GP may be deemed to beneficially own the 54,303 ordinary shares beneficially owned by SCP Vitalife Partners II and SCP Vitalife Israel Partners II. Jeff Dykan and Wayne B. Weisman are the directors of SCP Vitalife GP and, as such, share              voting and dispositive power over the shares held by the foregoing entities. As such, they may be deemed to beneficially own 60,003 ordinary shares, consisting of the 54,303 ordinary shares beneficially owned by SCP Vitalife GP, as well as              the ordinary shares beneficially owned by each of Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM and held by IIA. The principal business address of SCP Vitalife Partners II, SCP Vitalife Associates, SCP              Vitalife GP, and Messrs. Churchill and Weisman is c/o SCP Vitalife Partners II, L.P., 1200 Liberty Ridge Drive, Suite 300, Wayne, Pennsylvania 19087. The principal business address of SCP Vitalife Partners Israel II, Vitalife Partners Israel,              Vitalife Partners Overseas, Vitalife Partners DCM, Mr. Dykan and Dr. Ludomirski is c/o SCP Vitalife Partners (Israel) II, L.P., 32B Habarzel Street, Ramat Hachayal, Tel Aviv 69710, Israel. |

----

| (5)  | Consists of 5,975 ordinary shares, including 1,897 shares underlying RSUs vesting within 60 days, and exercisable options to purchase 501 ordinary              shares.                                                                                                                                                           |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (6)  | Consists of 11,223 ordinary shares, including 2,737 shares underlying RSUs vesting within 60 days.                                                                                                                                                                                                                                |
| (7)  | Consists of 11,283 ordinary shares, including 2,737 shares underlying RSUs vesting within 60 days, and exercisable options to purchase 501               ordinary shares.                                                                                                                                                    |
| (8)  | Consists of 6,874 ordinary shares, including 6,874 shares underlying RSUs vesting within 60 days.                                                                                                                                                                                                                                 |
| (9)  | Consists of 11,283 ordinary shares, including 2,737 shares underlying RSUs vesting within 60 days, and exercisable options to purchase 1,002 ordinary shares.                                                                                                                                                                     |
| (10) | Consists of 2,157 ordinary shares and exercisable options to purchase 3,961 ordinary shares.                                                                                                                                                                                                                                      |
| (11) | Consists of 12,586 ordinary shares and exercisable options to purchase 4,458 ordinary shares.                                                                                                                                                                                                                                     |
| (12) | Consists of (i) 126,945 ordinary shares directly or beneficially owned by our directors and executive officers; (ii) 42,816 ordinary shares constituting the cumulative aggregate number of              options granted to the executive officers and directors; and (iii) 22,456 shares underlying RSUs vesting within 60 days. |
| Plan Category                                              |   | Number of securities to be issued              upon exercise of outstanding options, warrants and rights(1)(2) |    | Weighted-average exercise price of outstanding              options, warrants and rights |   | Number of securities remaining available for future issuance under equity compensation              plans (excluding securities reflected in first column)(3) |   |
|------------------------------------------------------------|--------|----------------------------------------------------------------------------------------------------------------|---------|------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| Equity compensation plans approved by security holders     |   |                                                                                                           | 137,091 |                                                                                     | $      | 22.70                                                                                                                                                         |   |   | 12,409 |   |
| Equity compensation plans not approved by security holders |   |                                                                                                           | -       |                                                                                     |   | -                                                                                                                                                             |   |   | - |   |
| Total                                                      |   |                                                                                                           | 137,091 |                                                                                     | $      | 22.70                                                                                                                                                         |   |   | 12,409 |   |
| (1) | Represents shares issuable under our (i) 2014 Plan upon exercise of options outstanding to purchase 52,024 shares and upon the settlement of outstanding RSUs with respect to 62,378 shares,              (ii) 2012 Equity Incentive Plan upon exercise of options outstanding to purchase 22,002 shares, and (iii) 2006 Stock Option Plan upon exercise of options outstanding to purchase 687 shares.                                                                                      |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | The weighted average remaining term for the expiration of stock options is 6.34 years.                                                                                                                                                                                                                                                                                                                                                                                                       |
| (3) | Represents shares available for future issuance under our 2014 Plan. The number of our ordinary shares reserved for issuance under the 2014 Plan is automatically increased each January 1 of              each calendar year during the term of the 2014 Plan by a number of shares equal to the lesser of: (x) 38,800, (y) 4% of the total number of shares outstanding on December 31 of the immediately preceding calendar year, and (z) an amount              determined by our Board. |

----

|   | • | marketing, distribution and commercialization of our products by Yaskawa, subject to a separate distribution agreement;                 |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------|
|   | • | marketing and distribution of future Yaskawa healthcare equipment products by us in the scope of our sales network; and                 |
|   | • | improvement and quality control of our products by applying Yaskawa’s know-how and expertise in motion control and robotics. |

----

----

----

----

|  | • | a transaction other than in the ordinary course of business; |
|--|---------|--------------------------------------------------------------|
|  | • | a transaction that is not on market terms; or |
|--|---------|-----------------------------------------------|
|  | • | a transaction that may have a material impact on a company’s profitability, assets or liabilities. |
|--|---------|----------------------------------------------------------------------------------------------------------|

----

----

|                  |   | 2018             |   |   | 2019   |   |
|-----------------------|--------|------------------|--------|--------|--------|--------|
|                  |   | ($ in thousands) |   |
| Audit Fees(1)         |   | $                | 306    |   |   | $      | 255 |   |
| Audit-Related Fees(2) |   | $                | 10     |   |   |   | - |   |
| Tax Fees(3)           |   | $                | 19     |   |   | $      | 16 |   |
| All Other Fees(4)     |   | $                | 33     |   |   | $      | 16 |   |
| Total:                |   | $                | 368    |   |   | $      | 287 |   |
| (1) | “Audit fees” include fees for services performed by our independent public accounting firm in connection with our annual audit for 2018 and 2019, fees related to our at-the-market equity              offering program, follow-on offering of ordinary shares and follow-on offering of ordinary shares and warrants and fees for consultation concerning financial accounting and reporting standards. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | “Audit-related fees” relate to assurance and associated services that are traditionally performed by an independent auditor, including accounting consultation and consultation concerning              financial accounting, reporting standards and due diligence.                                                                                                                                      |
| (3) | “Tax fees” include fees for professional services rendered by our independent registered public accounting firm for tax compliance, transfer pricing and tax advice on actual or contemplated              transactions.                                                                                                                                                                                  |
| (4) | “All other fees” include fees for services rendered by our independent registered public accounting firm with respect to government incentives and other matters.                                                                                                                                                                                                                                         |

----

----

| ExhibitNumber | Exhibit Description                                                                                                                                       |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| 24.1          | Power of Attorney (included on the signature page of the Original Form 10-K (File No. 001-36612) filed with                the SEC on February 20, 2020). |
| 24.2**        | Power of Attorney for Randel Richner.                                                                                                                     |
| 31.3**        | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act                2002.                                       |
| 31.4**        | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act                2002.                                       |
| ** | Filed herewith. |
|----|-----------------|

----

|   |   | REWALK ROBOTICS LTD.    |
|--------|--------|-------------------------|
|   |   |                    |
|   | By:    | /s/ Ori Gon             |
|   |   | Ori Gon                 |
|   |   | Chief Financial Officer |

----

| Signature                | Title                                                                                 | Date              |
|--------------------------|---------------------------------------------------------------------------------------|-------------------|
|                     |                                                                                  |              |
| *                        |                                                                                  |              |
| Larry Jasinski           | Director and Chief Executive Officer(Principal Executive Officer)                     | December 18, 2020 |
|                     |                                                                                  |              |
| /s/ Ori Gon              |                                                                                  |              |
| Ori Gon                  | Chief Financial Officer(Principal Financial Officer and Principal Accounting Officer) | December 18, 2020 |
|                     |                                                                                  |              |
| *                        |                                                                                  |              |
| Jeff Dykan               | Chairman of the Board                                                                 | December 18, 2020 |
|                     |                                                                                  |              |
| *                        |                                                                                  |              |
| Dr. John William Poduska | Director                                                                              | December 18, 2020 |
|                     |                                                                                  |              |
| *                        |                                                                                  |              |
| Yohanan Engelhardt       | Director                                                                              | December 18, 2020 |
|                     |                                                                                  |              |
| *                        |                                                                                  |              |
| Wayne B. Weisman         | Director                                                                              | December 18, 2020 |
|                     |                                                                                  |              |
| *                        |                                                                                  |              |
| Yasushi Ichiki           | Director                                                                              | December 18, 2020 |
|                     |                                                                                  |              |
| *                        |                                                                                  |              |
| Aryeh Dan                | Director                                                                              | December 18, 2020 |
|                     |                                                                                  |              |
| *                        |                                                                                  |              |
| Randel Richner           | Director                                                                              | December 18, 2020 |

----